The Effect of SMN Gene Dosage on ALS Risk and Disease Severity. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ana.26009
PubMed Identifier: 33389754
Publication URI: http://europepmc.org/abstract/MED/33389754
Type: Journal Article/Review
Volume: 89
Parent Publication: Annals of neurology
Issue: 4
ISSN: 0364-5134